# Status

The OpenStudyBuilder is an open source project which was released in October 2022 for the public. The agile development contineusly releases new versions in GitLab. Since October 2022 Novo Nordisk performed two pilot studies to enhance the solution further. On October 31, 2023, Novo Nordisk launched of the first business release of the internal OpenStudyBuilder. From now on all phase 2 and 3 studies in Novo Nordisk use the OpenStudyBuilder to generate study protocol parts. For 2025 it is planned to enlarge the scope for phase 1 studies and use the solution as metadata repository.

## Communication

We use the following communication types:

- Workshops (please see [events](./info_events.md) for upcoming ones)
- Presentations (please see [events](./info_events.md) for upcoming ones)
- Monthly community meetings (please see [events](./info_events.md) for upcoming ones)
- Direct meetings with companies to show the tool and discuss collaborations
- Newsletter (subscribe on LinkedIn [here](https://www.linkedin.com/newsletters/openstudybuilder-6990328054849916928/){target=_blank})
- Slack (join [here](https://join.slack.com/t/openstudybuilder/shared_invite/zt-19mtauzic-Jvrhtmy7hGstgyiIvB1Wsw){target=_blank})
- Community mail (<a href="mailto:OpenStudyBuilder@gmail.com">OpenStudyBuilder@gmail.com</a>)
- Community project Slack (join [here](https://join.slack.com/t/osb-mdr/shared_invite/zt-2iwjqjg76-r0NW6pRH5GnGQQ~~izLc_A){target=_blank})

